Εμφάνιση απλής εγγραφής

dc.creatorGiamarellos-Bourboulis, E. J.en
dc.creatorApostolidou, E.en
dc.creatorLada, M.en
dc.creatorPerdios, I.en
dc.creatorGatselis, N. K.en
dc.creatorTsangaris, I.en
dc.creatorGeorgitsi, M.en
dc.creatorBristianou, M.en
dc.creatorKanni, T.en
dc.creatorSereti, K.en
dc.creatorKyprianou, M. A.en
dc.creatorKotanidou, A.en
dc.creatorArmaganidis, A.en
dc.date.accessioned2015-11-23T10:27:53Z
dc.date.available2015-11-23T10:27:53Z
dc.date.issued2013
dc.identifier10.1186/cc13073
dc.identifier.issn13648535
dc.identifier.urihttp://hdl.handle.net/11615/27841
dc.description.abstractIntroduction: The aim of this study was to investigate the kinetics of immunoglobulin M (IgM) during the different stages of sepsis. Methods: In this prospective multicenter study, blood sampling for IgM measurement was done within the first 24 hours from diagnosis in 332 critically ill patients; in 83 patients this was repeated upon progression to more severe stages. Among these 83 patients, 30 patients with severe sepsis progressed into shock and IgM was monitored daily for seven consecutive days. Peripheral blood mononuclear cells (PBMCs) were isolated from 55 patients and stimulated for IgM production. Results: Serum IgM was decreased in septic shock compared to patients with systemic inflammatory response syndrome (SIRS) and patients with severe sepsis. Paired comparisons at distinct time points of the sepsis course showed that IgM was decreased only when patients deteriorated from severe sepsis to septic shock. Serial measurements in these patients, beginning from the early start of vasopressors, showed that the distribution of IgM over time was significantly greater for survivors than for non-survivors. Production of IgM by PBMCs was significantly lower at all stages of sepsis compared with healthy controls. Conclusions: Specific changes of circulating IgM occur when patients with severe sepsis progress into septic shock. The distribution of IgM is lower among non-survivors. © 2013 Giamarellos-Bourboulis et al.; licensee BioMed Central Ltd.en
dc.source.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-84885707035&partnerID=40&md5=9f6be010015f59f71580b8cffe0cfef2
dc.subjectC reactive proteinen
dc.subjecthypertensive factoren
dc.subjectimmunoglobulin Men
dc.subjectageden
dc.subjectarticleen
dc.subjectblood samplingen
dc.subjectcontrolled studyen
dc.subjectcritically ill patienten
dc.subjectdisease courseen
dc.subjectdisease severityen
dc.subjectfemaleen
dc.subjecthumanen
dc.subjectkineticsen
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectmulticenter studyen
dc.subjectoutcome assessmenten
dc.subjectperipheral blood mononuclear cellen
dc.subjectpriority journalen
dc.subjectsepsisen
dc.subjectseptic shocken
dc.subjectsurvivoren
dc.subjectsystemic inflammatory response syndromeen
dc.subjectAPACHEen
dc.subjectblooden
dc.subjectclinical trialen
dc.subjectcritical illnessen
dc.subjectGreeceen
dc.subjectmononuclear cellen
dc.subjectprognosisen
dc.subjectprospective studyen
dc.subjectShock, Septicen
dc.subjecttreatment outcomeen
dc.subjectHumansen
dc.subjectLeukocytes, Mononuclearen
dc.subjectProspective Studiesen
dc.titleKinetics of circulating immunoglobulin M in sepsis: Relationship with final outcomeen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής